Rozina Parbtani

Rozina Parbtani practices at HCA Florida Westside Hospital in Plantation, Florida, part of HCA Healthcare.

Rozina Parbtani's NPI, 1326577925, was assigned on June 7, 2017. Rozina Parbtani holds Florida license ME148401.

Rozina Parbtani's primary practice is HCA Florida Westside Hospital, at 8201 W Broward Blvd, Plantation, FL 33324 in Broward County. The practice phone is (954) 473-6600.

Rozina Parbtani's primary practice is HCA Florida Westside Hospital in Plantation, Florida, part of HCA Healthcare. The medical group on file is HHA Physician Associates. Dmand AI also links Rozina Parbtani to 1 more breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rozina Parbtani practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Rozina Parbtani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Rozina Parbtani is licensed in Florida.

CMS data shows 526 Medicare services from Rozina Parbtani across 5 procedure codes in 2024, for 181 Medicare patients. Medicare paid $48,940 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 181 Medicare patients who saw Rozina Parbtani in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rozina Parbtani's median patient age at 67, with 53% women.

In 2024, Rozina Parbtani wrote 422 Medicare Part D claims for 225 patients. 89% of them were for generic drugs. CMS names the drug for 202 of them, across 10 drugs with 11 or more claims each, at $894 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

Rozina Parbtani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Rozina Parbtani from 1 drug or device company from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $105.